Addex Therapeutics Ltd ADR (ADXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADXN | CANF | IKT | ||
| Company | Addex Therapeutics Ltd ADR | Can-Fite Biopharma Ltd ADR | Inhibikase Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 7.97 | 2.39 | 1.1500 | ||
| High | 8.29 | 2.48 | 1.2550 | ||
| Low | 7.84 | 2.36 | 1.1450 | ||
| Last | 7.84 | 2.42 | 1.1505 | ||
| Change | unch | +0.02 | -0.0595 | ||
| % Change | +0.06% | +0.83% | -4.92% | ||
| Volume | 3,400 | 21,700 | 68,000 | ||
| 20-Day Average Volume | 3,970 | 133,385 | 24,950 | ||
| Previous Close | 7.84 | 2.40 | 1.2100 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 8.45 | 2.77 | 1.4520 | ||
| 20-Day Raw Stochastic | 16.50% | 5.50% | 2.93% | ||
| 20-Day Relative Strength | 38.93% | 46.72% | 35.32% | ||
| Weighted Alpha | -51.99 | -27.58 | -72.93 | ||
| Today's Opinion | 72% Sell | 64% Buy | 88% Sell | ||
| Previous Opinion | 72% Sell | 64% Buy | 88% Sell | ||
| Last Month's Opinion | 40% Sell | 72% Buy | 16% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.82% since 06/24/24 | -8.68% since 06/26/24 | -18.40% since 06/26/24 | ||
| Low | 7.76 on 06/27/24 | 2.30 on 07/02/24 | 1.1300 on 07/01/24 | ||
| High | 8.29 on 07/02/24 | 2.74 on 06/27/24 | 1.5200 on 06/27/24 | ||
| 1-Month | |||||
| %Chg | -8.84% since 05/31/24 | +0.41% since 06/03/24 | -38.15% since 06/03/24 | ||
| Low | 7.50 on 06/17/24 | 2.30 on 07/02/24 | 1.1300 on 07/01/24 | ||
| High | 9.56 on 06/05/24 | 4.48 on 06/14/24 | 1.9197 on 06/04/24 | ||
| 3-Month | |||||
| %Chg | -40.79% since 04/02/24 | +5.68% since 04/03/24 | -46.49% since 04/03/24 | ||
| Low | 7.50 on 04/29/24 | 1.91 on 04/26/24 | 1.1300 on 07/01/24 | ||
| High | 27.90 on 04/09/24 | 4.48 on 06/14/24 | 2.3000 on 04/16/24 | ||
| 6-Month | |||||
| %Chg | +24.48% since 01/02/24 | +17.48% since 01/03/24 | -12.84% since 01/03/24 | ||
| Low | 6.00 on 01/10/24 | 1.87 on 01/19/24 | 1.1300 on 07/01/24 | ||
| High | 27.90 on 04/09/24 | 4.48 on 06/14/24 | 3.8200 on 01/25/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,307 | 8,567 | 8,302 | ||
| Shares Outstanding, K | 1,060 | 3,540 | 7,216 | ||
| Annual Sales | 1,800,000 | 740,000 | 260,000 | ||
| Annual Net Income | -11,760,000 | -7,630,000 | -19,030,000 | ||
| Last Quarter Sales | 270,000 | 160,000 | 0 | ||
| Last Quarter Net Income | -3,530,000 | -1,650,000 | -4,180,000 | ||
| 60-Month Beta | 1.77 | 1.45 | 1.32 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.37 on 06/06/24 | -0.31 on 03/28/24 | -0.73 on 05/15/24 | ||
| Latest Earnings Date | 08/08/24 | 07/04/24 | 08/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||